Laparoscopy-Assisted Surgery for Carcinoma of the Low Rectum

NCT01899547 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1070

Last updated 2021-10-01

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and oncological feasibility of laparoscopy-assisted surgery for low rectal carcinoma compared with open surgery.

Conditions

  • Rectal Carcinoma

Interventions

PROCEDURE

laparoscopic-assisted rectal resection

Arm I: Patients undergo laparoscopic-assisted rectal resection.

PROCEDURE

conventional open rectal resection

Arm II: Patients undergo conventional open rectal resection.

Sponsors & Collaborators

  • Sixth Affiliated Hospital, Sun Yat-sen University

    collaborator OTHER
  • Nanfang Hospital, Southern Medical University

    collaborator OTHER
  • Peking Union Medical College Hospital

    collaborator OTHER
  • Peking University Cancer Hospital & Institute

    collaborator OTHER
  • Chinese PLA General Hospital

    collaborator OTHER
  • Liaoning Cancer Hospital & Institute

    collaborator OTHER
  • RenJi Hospital

    collaborator OTHER
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    collaborator OTHER
  • West China Hospital

    collaborator OTHER
  • Shengjing Hospital

    collaborator OTHER
  • Fujian Cancer Hospital

    collaborator OTHER_GOV
  • The Second Affiliated Hospital of Fujian Medical University

    collaborator OTHER
  • The First Affiliated Hospital of Xiamen University

    collaborator OTHER
  • Zhangzhou Affiliated Hospital of Fujian Medical University

    collaborator OTHER
  • Longyan Affiliated Hospital, Fujian Medical University

    collaborator UNKNOWN
  • Fudan University

    collaborator OTHER
  • Shanghai Zhongshan Hospital

    collaborator OTHER
  • Sun Yat-sen University

    collaborator OTHER
  • Hubei Cancer Hospital

    collaborator OTHER
  • Zhejiang Cancer Hospital

    collaborator OTHER
  • Fujian Medical University

    lead OTHER

Principal Investigators

  • Pan Chi, MD · Fujian Medical University Union Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-12
Primary Completion
2021-12-31
Completion
2023-06-06

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01899547 on ClinicalTrials.gov